Acute Coronary Syndrome News and Research

RSS

LifePoint Hospitals partners with SCPC to achieve Chest Pain Center Accreditation

LifePoint Hospitals, a leading company focused on providing quality healthcare services close to home, and the Society of Cardiovascular Patient Care have partnered to support LifePoint facilities in attaining Chest Pain Center Accreditation. The effort, which SCPC reports is its first system-wide collaboration of such size, demonstrates LifePoint's commitment to excellence in quality, patient safety and overall patient care.

7 Feb 2015

Adding ezetimibe to statin therapy reduces cardiovascular events

More than a decade ago, researchers from Brigham and Women's Hospital demonstrated that a high dose statin, which lowered cholesterol further than a regular dose statin, provided better clinical outcomes. But questions remained about whether further reducing cholesterol would be even more effective in reducing cardiovascular-related events.

18 Nov 2014

Using cardiac biomarkers to identify NSTEMI and ACS patients: an interview with Peter Mason

ACS is currently identified through the use of ECGs pre-hospital and the confirmed via a Troponin biomarker test once in the acute setting.

16 Nov 2014

Studies evaluate traditional management of heart attack patients after discharge from hospital

Beta-blockers have been a cornerstone in the treatment of heart attack survivors for more than a quarter of a century. However, many of the data predate contemporary medical therapy such as reperfusion, statins, and antiplatelet agents, and recent data have called the role of beta-blockers into question.

12 Nov 2014

Cardiome Pharma announces results from Phase 3 clinical study of BRINAVESS

Cardiome Pharma Corp. today announced results from a Phase 3 clinical study conducted with BRINAVESS (vernakalant intravenous, RSD 1235) in the Asia-Pacific (A-P) region.

7 Nov 2014

First-ever evidence-based guidelines released for prevention of acute COPD exacerbations

The American College of Chest Physicians (CHEST) and the Canadian Thoracic Society (CTS) announced today the release of Prevention of Acute Exacerbation of Chronic Obstructive Pulmonary Disease: American College of Chest Physicians and Canadian Thoracic Society Guideline in the journal CHEST.

17 Oct 2014

Darapladib drug fails to reduce risk of recurrent major coronary events

In patients who experienced an acute coronary syndrome (ACS) event (such as heart attack or unstable angina), use of the drug darapladib to inhibit the enzyme lipoprotein-associated phospholipase A2 (believed to play a role in the development of atherosclerosis) did not reduce the risk of recurrent major coronary events, according to a study published by JAMA.

1 Sep 2014

Study: Resistant hypertension increases risk of stroke in female and elderly patients

Resistant hypertension increases the risk of stroke by 35% in women and 20% in elderly Taiwanese patients, according to research presented at ESC Congress today by Dr Kuo-Yang Wang from Taiwan.

1 Sep 2014

ESC Guidelines on diagnosis and treatment of aortic diseases published in European Heart Journal

The first comprehensive ESC Guidelines on aortic diseases are published today. They are presented at ESC Congress 2014 by Task Force Chairpersons Professor Raimund Erbel (Germany) and Professor Victor Aboyans (France).

30 Aug 2014

Recommendations on arrhythmia management in ACS patients published in EP Europace

The first multidisciplinary recommendations on the management of arrhythmias in patients with acute coronary syndromes (ACS) are published today in EP Europace.

30 Aug 2014

ACCA Clinical Decision-Making Toolkit mobile app helps make quick and correct decision

The ACCA Clinical Decision-Making Toolkit mobile app is now available on the App Store and Google Play. When dealing with acute cardiovascular diseases, a few seconds can make the difference and instant access to the best recommendations can save lives.

30 Aug 2014

Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO

Janssen Research & Development, LLC and its development partner, Bayer HealthCare, announced today the expansion of the EXPLORER global cardiovascular research program for XARELTO (rivaroxaban) to include additional high-risk patient populations.

29 Aug 2014

Experts open new clinic to evaluate heart disease patients for participation in stem cell studies

Regenerative medicine experts at the Cedars-Sinai Heart Institute have opened a new clinic to evaluate heart and vascular disease patients for participation in stem cell medical studies.

13 Aug 2014

Cardiome Pharma reports record revenues in second quarter 2014

Cardiome Pharma Corp. today reported financial results for the second quarter and six months ended June 30, 2014.

11 Aug 2014

Improving care, outcomes for NSTEMI patients linked to higher survival rates

Changes in the treatment of the most common form of heart attack over the past decade have been associated with higher survival rates for men and women regardless of age, race and ethnicity, according to a UCLA-led analysis.

5 Aug 2014

EMA CHMP issues positive opinion for label updates to Takeda's Vipidia, Vipdomet and Incresync

Takeda Pharmaceuticals International GmbH today announced that the Committee for Medicinal Products for Human Use of the European Medicines Agency has issued positive opinions for updates to the Summary of Product Characteristics (SmPC) for Vipidia (alogliptin) and the fixed-dose combination (FDC) therapies Vipdomet (alogliptin and metformin) and Incresync (alogliptin and pioglitazone).

30 Jul 2014

Acute Coronary Syndrome News and Research

LifePoint Hospitals partners with SCPC to achieve Chest Pain Center Accreditation

Adding ezetimibe to statin therapy reduces cardiovascular events

Using cardiac biomarkers to identify NSTEMI and ACS patients: an interview with Peter Mason

Studies evaluate traditional management of heart attack patients after discharge from hospital

Cardiome Pharma announces results from Phase 3 clinical study of BRINAVESS

First-ever evidence-based guidelines released for prevention of acute COPD exacerbations

Darapladib drug fails to reduce risk of recurrent major coronary events

Study: Resistant hypertension increases risk of stroke in female and elderly patients

ESC Guidelines on diagnosis and treatment of aortic diseases published in European Heart Journal

Recommendations on arrhythmia management in ACS patients published in EP Europace

ACCA Clinical Decision-Making Toolkit mobile app helps make quick and correct decision

Janssen, Bayer announce expansion of EXPLORER global cardiovascular research program for XARELTO

Experts open new clinic to evaluate heart disease patients for participation in stem cell studies

Cardiome Pharma reports record revenues in second quarter 2014

Improving care, outcomes for NSTEMI patients linked to higher survival rates

EMA CHMP issues positive opinion for label updates to Takeda's Vipidia, Vipdomet and Incresync

Clinical judgement with ECG and blood test effective in reducing hospital admissions for chest pain

New study explores relationship between personality and heart attacks

Findings shed light on possible role of affective temperaments in cardiovascular morbidity

Researchers use simple tactics to reduce unnecessary blood tests, health care spending

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News